{"nct_id":"NCT05033080","title":"A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2021-09-14","start_date_type":"ACTUAL","primary_completion_date":"2023-05-12","primary_completion_date_type":"ACTUAL","completion_date":"2023-11-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["VRTX"]}